Chennai maker of consumer brands, TTK Chitra heart valves, Skore condoms & animal-health/food products
Price
Market Cap
Sector
Diversified
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 235 | 281 | 316 | 939 | 987 | 1.1k | 1.1k | 1.1k |
| Borrowings | 30 | 19 | 22 | 27 | 23 | 24 | 27 | 24 |
| Other Liabilities | 152 | 180 | 207 | 189 | 183 | 192 | 184 | 190 |
| Total Liabilities | 431 | 494 | 559 | 1.2k | 1.2k | 1.3k | 1.3k | 1.3k |
| AssetsFixed Assets | 89 | 85 | 80 | 71 | 75 | 81 | 78 | 73 |
| CWIP | 9 | 0 | 0 | 3 | 1 | 0 | 0 | 1 |
| Investments | 9 | 13 | 15 | 13 | 13 | 11 | 12 | 9 |
| Other Assets | 325 | 395 | 463 | 1.1k | 1.1k | 1.2k | 1.2k | 1.2k |
| Total Assets | 431 | 494 | 559 | 1.2k | 1.2k | 1.3k | 1.3k | 1.3k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 17 | 20 | 96 | 45 | -25 | -5 | -4 | -21 |
| Cash from Investing | 10 | -13 | -77 | -30 | 32 | 28 | 20 | 52 |
| Cash from Financing | -31 | -10 | -17 | -10 | -12 | -22 | -18 | -18 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 13 | 8 | 95 | 42 | -36 | -15 | 6 | -25 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (27.1×) and current (20.0×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 9.7% growth and a 20× exit, ₹929 only delivers your return if you pay ₹635. The price is currently baking in 18% growth.
EPS grows 9.7%/yr for 5 years, then fades to 6% over 2, exits at 20×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 9.7% | 50.99 |
| FY28 | 9.7% | 55.93 |
| FY29 | 9.7% | 61.36 |
| FY30 | 9.7% | 67.31 |
| FY31 | 9.7% | 73.84 |
| FY32 | 7.8% ·fade | 79.64 |
| FY33 | 6.0% ·fade | 84.42 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.